HOME >> BIOLOGY >> NEWS
Cytokine resistance contributes to pathology of type 2 diabetes

In a study appearing this month in the Journal of Immunology, researchers at the University of Illinois describe how an impaired anti-inflammatory response plays a role in the pathology of type 2 diabetes.

Type 2 diabetes is classified as a metabolic disorder, but a growing number of researchers are beginning to think of it also as a disease of the innate immune system. Inflammation, a key component of the early immune response, is chronically elevated in people with type 2 diabetes. While the pro-inflammatory pathways of type 2 diabetes have received much attention, the anti-inflammatory side of the equation is less well known.

The new study focused on a number of cytokines, protein signals that bind to specific receptors on cells and set off a cascade of biochemical reactions within the cell. Interleukins, interferons, tumor necrosis factors and some growth factors are among the cytokines that direct many aspects of the immune response. Cytokines are secreted by many types of cells, including the immune cells known as macrophages.

In earlier studies, the researchers had shown that macrophages in diabetic and obese (diabese) mice secrete more pro-inflammatory and less anti-inflammatory cytokines than those of nondiabese mice. The team, led by pathology professor and department head Gregory Freund, also had demonstrated that human monocytes cultured under type 2 diabetic conditions had impaired interleukin-4 signaling. Interleukin 4 (IL-4) is an important player in the immune response in that it steers macrophages toward the production of other anti-inflammatory cytokines. It also inhibits secretion of the pro-inflammatory cytokines.

When IL-4 binds to its receptor on a target cell, it sets off one of two cascades of intracellular events.

The first of these signal transduction pathways, the Jak-STAT pathway, is well studied and well understood. The second, called the insulin receptor substrate 2 / phosphatidylinos
'"/>

Contact: Diana Yates
diya@uiuc.edu
217-333-5802
University of Illinois at Urbana-Champaign
14-Jun-2007


Page: 1 2

Related biology news :

1. Cytokinetics presents data on CK-1827452
2. Support for chromosomal theory of cancer found in cancers development of drug resistance
3. 454 sequencing identifies HIV drug resistance at early stage
4. Ultra deep sequencing identifies HIV drug resistance at early stage
5. Largest synthetic gene ever built offers insights into anti-malarial drug resistance
6. WHO data confirms low level of resistance to Tamiflu
7. Unstable leukemia stem cells may predispose patients to drug resistance
8. Gene profiling predicts resistance to breast cancer drug Herceptin
9. IDIBAPS participates in European Network on antibiotic resistances and hospital infections
10. What recognizes what in plant disease resistance?
11. Antiretroviral resistance testing in HIV infected patients improves health and saves costs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/18/2019)... ... March 18, 2019 , ... uBiome, the leader in ... third highest quality portfolio following Seres Health and Nestle, as published in ... Theodor Myfleler. uBiome executives Dr. Jessica Richman, PhD, co-founder and CEO, Dr. Zachary ...
(Date:3/14/2019)... (PRWEB) , ... March 14, 2019 , ... ... configurations on Mac, Windows and mobile, today announces the launch of its North ... sales volume, geographies and vertical markets, enabling them to add FileWave’s industry-leading solutions ...
(Date:3/13/2019)... ... March 13, 2019 , ... Sleep problems constitute a global epidemic that ... the world’s population. One billion people worldwide suffer from sleep apnea - ... than 80 percent of whom go undiagnosed. Today, Beddr , the sleep health ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... ... March 19, 2019 , ... ... hospital in Israel and the Middle East region, and Swiss-based CDMO Lonza ... manufacturing platform. The partnership will enable Sheba to vastly streamline its in-house ...
(Date:3/18/2019)... ... ... For more than 15 years, USDM Life Sciences and ... easily comply with FDA 21 CFR Part 11 and EMA EudraLex Volume 4 Annex ... GxP compliance from vendor audit through ongoing validation maintenance, including every new release. ...
(Date:3/14/2019)... ... March 14, 2019 , ... EyeCRO LLC has ... OK. EyeCRO joins the Department of Veterans Affairs, the Oklahoma Medical Research Foundation, ... fifth institution in Oklahoma to receive this prestigious endorsement. The award letter ...
(Date:3/14/2019)... ... March 14, 2019 , ... Open registration for the ... Full Spectrum of Case Management,” continues as CMSA makes plans to host the ... only case management industry conference serving the educational and networking needs of case ...
Breaking Biology Technology:
Cached News: